Stock screener

AUPH

Conviction 54HealthcareScan · Thu, Sep 24, 2026

Aurinia Pharmaceuticals Inc. (AUPH) closed at $16.59 (+1.16%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 54, RS Rating 76, -10.9% from its 52-week high, +8.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

AUPH$16.59+1.16%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 850.33K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Aurinia Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.auriniapharma.com ↗
Price16.59
Change+1.16%
Gap-0.30%
Rel volume1.22×
Avg volume829.6K
Avg $ vol13.62M
SMA 2016.38
SMA 5015.91
SMA 20015.54
Price vs 50+4.25%
Price vs 200+6.76%
MA stackbullish
50/200 cross—
Supertrendup · 15.54
RSI (14)54
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D56 / 54
ADX (14)29
+DI / −DI23 / 15
RSI divergence—
MACD divergence—
ATR %2.77%
ADR %2.44%
52w high18.62
52w low11.05
From 52w high-10.90%
Above 52w low+50.14%
New 52w highNo
SqueezeOn · 5d
Bollinger width7.36%
%B0.68
Donchian pos56.49%
Donchian high17.16
Donchian low15.85
AVWAP (52w high)16.24
vs AVWAP high+2.14%
AVWAP (52w low)15.10
vs AVWAP low+9.86%
OBV trendDown
Chaikin MF (20)0.02
Today vs 20d1.22×
Avg vol (14d)850.33K
Avg vol (20d)829.6K
Avg $ vol (20d)13.62M
Market cap2.21B
RS Rating76 / 99
RS 3m (vs SPY)-9.96%
RS 6m (vs SPY)-1.37%
RS line new highNo
Trend template7/8
Technical rank75.4
1 week-2.18%
1 month-0.96%
3 months-5.47%
6 months+15.45%
1 year+27.62%
YTD+8.08%
P/E7.69
P/B3.59
P/S7.80
P/FCF—
EPS2.07
Div yield—
ROE46.71%
ROA36.25%
Debt/Eq—
Current5.42
EV/EBITDA16.30
Gross margin—
Net margin101.47%
Rev growth20.38%
EPS growth4893.08%
Price target18.00
Target upside8.50%
Analyst ratingBuy
Institutional63.21%
Ent. value2.03B
Revenue83.22M
Net income37.41M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out128.6M
Employees128
ListedWed, Oct 21, 2009
Free float109.81M
Float %82.6%
Short interest8.98M
Days to cover8.6d
Short volume46.5%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.28 vs $0.18
Last surprise+55.6% beat
Setup gradeC
Conviction54 / 100
Pattern quality—
Tech rank75.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance17.48
Support15.38
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AUPH

All disclosures →
No recent disclosed trades by Congress in AUPH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AUPH · open-market 2 buys · 2 sells

InsiderSideShares
Robertson Stephen P.
Chief Legal Officer · Common Stock · 2026-09-10
Sell11.94K
Robertson Stephen P.
Chief Legal Officer · Common Stock · 2026-08-21
Sell20.98K
Johnson Craig A
Director · Director Stock Option (right to buy) · 2026-06-04
Grant23.93K
Bailey Jeffrey Allen
Director · Director Stock Option (right to buy) · 2026-06-04
Grant23.93K
Nova Tina Susan
Director · Director Stock Option (right to buy) · 2026-06-04
Grant23.93K
Goetz Kathleen
Director · Director Stock Option (right to buy) · 2026-06-04
Grant23.93K
TANG CAPITAL MANAGEMENT LLC
10% owner · Common Shares · 2026-06-02
Buy206K
TANG KEVIN
Chief Executive Officer · Short Put Options (potential obligation to buy) · 2026-06-02
Acquire10K
TANG CAPITAL MANAGEMENT LLC
10% owner · Short Put Options (potential obligation to buy) · 2026-06-02
Acquire10K
TANG KEVIN
Chief Executive Officer · Common Shares · 2026-06-02
Buy206K

SEC filings

EDGAR filings in AUPH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.